Streetbeat News

Products Services

TNYA

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) will present data related to its TN-201 and TN-301 programs at the 2023 Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions and the Heart Failure Society of America (HFSA) Annual Scientific Meeting. The data includes results from the Phase 1 clinical trial of TN-301 and interim data from an ongoing seroprevalence study of TN-201.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:10 pm

VCYT

Veracyte, Inc. (NASDAQ:VCYT) announced that three posters showcasing new data from the company's Afirma Genomic Sequencing Classifier (GSC) will be presented at the 2023 American Thyroid Association (ATA) Annual Meeting. The abstracts offer insights into the molecular underpinnings of thyroid nodules and tumors based on whole-transcriptome RNA sequencing data. The company believes that Afirma-based whole-transcriptome analysis will advance cancer research and may be used in clinical care.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:09 pm

QDEL

QuidelOrtho Corporation (NASDAQ:QDEL) has been granted a CLIA Waiver from the U.S. Food and Drug Administration (FDA) for its Sofia 2 SARS Antigen+ FIA, a rapid antigen test that detects COVID-19. The waiver means the test is simple and low risk enough to be used in any point-of-care setting equipped with Sofia 2 instruments, without the need for trained clinical laboratory personnel. The Sofia 2 analyzer provides an accurate, objective and automated result in just 10 minutes.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:08 pm

HRMY

Scorpion Capital has received an interim response from the FDA regarding their petition to withdraw approval of Harmony Biosciences' drug Wakix. The FDA has stated that the petition raises complex issues requiring extensive review and analysis. The final decision is expected within two weeks.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 7:50 pm

GOOG

GOOGL

MSFT

NVDA

PLTR

Max Tegmark, MIT professor and co-founder of the Future of Life Institute, warns of a relentless “race to the bottom” among tech companies in the development of advanced artificial intelligence (AI) systems. Despite an open letter signed by over 30,000 people including Elon Musk and Steve Wozniak, calling for a six-month hiatus on the creation of AI models exceeding the power of GPT-4, tech companies continue to compete in AI development. The race has sparked fears of creating unmanageable, superintelligent AI, prompting calls for government intervention. Tech executives from companies like Alphabet Inc’s Google, Microsoft Corporation, Nvidia Corp, Palantir Technologies Inc, OpenAI, Anthropic, and others are involved in global discussions on AI.

Portfolio Pulse from AJ Fabino

September 21, 2023 | 7:41 pm

VFS

VinFast expects to deliver between 40,000 and 50,000 vehicles in FY2023. The company is on track to start delivering the VF 9 in North America and the VF 6 in Vietnam by the end of this year. Deliveries of VF 7 and VF 3 are expected to commence in 2024. The company's capex for 2023-24 is expected to remain at the level incurred in 1H2023. VinFast believes it has sufficient growth potential in the coming years and continues to seek opportunities to strengthen its balance sheet.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 7:41 pm

VFS

VinFast has reported its unaudited financial results for Q2 2023. The company's quarterly revenues reached $334.1M, a 131.2% increase from Q2 2022 and a 303.3% increase from Q1 2023. Vehicle sales were $314.6M, up 147.0% from Q2 2022 and 387.3% from Q1 2023. The company delivered 9,535 EVs, a 436% increase from Q1 2023. However, the company reported a net loss of $526.7M, though this is an improvement from previous quarters.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 7:37 pm

MSFT

The US Army has awarded Microsoft a $95 million contract for the next stage of the Integrated Visual Augmentation System (IVAS) program. The technology, based on Microsoft's HoloLens 2 device, is a high-priority modernization initiative for the Army. The new variant, IVAS 1.2, has received positive feedback from initial testing. The contract includes the development and delivery of 280 pre-production IVAS 1.2 systems and 11 soldier immersive virtual trainers. The program could be worth up to $21.9 billion if fully realized.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 7:36 pm

MSFT

NVDA

Microsoft's game Starfield has reached over 10 million players in less than three weeks, marking Bethesda's biggest launch ever. The game was available on PC and Xbox Series X and S, and also on Game Pass. It was the best-selling game in Europe during its launch week and the fastest-selling new IP of the year. Nvidia released an update to improve the performance of Starfield on RTX 30 and 40-series graphics cards.

Portfolio Pulse from Franca Quarneti

September 21, 2023 | 7:29 pm

MSFT

Wedbush analyst Daniel Ives reiterated an Outperform rating on Microsoft Corp (NASDAQ:MSFT) with a $400 price target. Ives believes that AI adoption is happening quicker than expected, which could drive strong growth for Microsoft. The company's Azure checks show an uptick in AI-driven activity, which could lead to Microsoft exceeding its 25%-26% Azure growth guidance in FY1Q. Ives also estimates that for every $100 of cloud Azure spent with Microsoft in the last few years, there is an incremental $35-$40 of AI spent now on the table.

Portfolio Pulse from Anusuya Lahiri

September 21, 2023 | 6:59 pm